Free Trial
→ Trump's New Dollar (From Porter & Company) (Ad)tc pixel Free TRLV Stock Alerts

Trulieve Cannabis (TRLV) Competitors

Trulieve Cannabis logo
$9.48 +0.08 (+0.85%)
As of 03:52 PM Eastern
Compare

TRLV vs. AIMDW, ALVOW, ARAV, ACABW, and BFRIW

Should you buy Trulieve Cannabis stock or one of its competitors? MarketBeat compares Trulieve Cannabis with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Trulieve Cannabis include Ainos (AIMDW), Alvotech (ALVOW), Aravive (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), and Biofrontera (BFRIW). These companies are all part of the "pharmaceutical products" industry.

How does Trulieve Cannabis compare to Ainos?

Ainos (NASDAQ:AIMDW) and Trulieve Cannabis (NYSE:TRLV) are both pharmaceutical products companies, but which is the better business? We will compare the two businesses based on the strength of their risk, analyst recommendations, earnings, media sentiment, dividends, profitability, institutional ownership and valuation.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ainos$18.11KN/AN/AN/AN/A
Trulieve Cannabis$1.17B1.38N/AN/AN/A

In the previous week, Ainos' average media sentiment score of 1.87 beat Trulieve Cannabis' score of 0.00 indicating that Ainos is being referred to more favorably in the media.

Company Overall Sentiment
Ainos Very Positive
Trulieve Cannabis Neutral

Company Net Margins Return on Equity Return on Assets
AinosN/A N/A N/A
Trulieve Cannabis N/A N/A N/A

Summary

Ainos and Trulieve Cannabis tied by winning 1 of the 2 factors compared between the two stocks.

How does Trulieve Cannabis compare to Alvotech?

Trulieve Cannabis (NYSE:TRLV) and Alvotech (NASDAQ:ALVOW) are both pharmaceutical products companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, earnings, profitability, institutional ownership, valuation, media sentiment and analyst recommendations.

Company Net Margins Return on Equity Return on Assets
Trulieve CannabisN/A N/A N/A
Alvotech N/A N/A N/A

In the previous week, Alvotech's average media sentiment score of 1.89 beat Trulieve Cannabis' score of 0.00 indicating that Alvotech is being referred to more favorably in the news media.

Company Overall Sentiment
Trulieve Cannabis Neutral
Alvotech Very Positive

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Trulieve Cannabis$1.17B1.38N/AN/AN/A
Alvotech$559.42MN/AN/AN/AN/A

Summary

Trulieve Cannabis and Alvotech tied by winning 1 of the 2 factors compared between the two stocks.

How does Trulieve Cannabis compare to Aravive?

Aravive (NASDAQ:ARAV) and Trulieve Cannabis (NYSE:TRLV) are both pharmaceutical products companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, earnings, media sentiment, profitability, valuation, risk and institutional ownership.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AraviveN/AN/AN/A-$0.90N/A
Trulieve Cannabis$1.17B1.38N/AN/AN/A

Company Net Margins Return on Equity Return on Assets
AraviveN/A N/A N/A
Trulieve Cannabis N/A N/A N/A

In the previous week, Aravive's average media sentiment score of 0.00 equaled Trulieve Cannabis'average media sentiment score.

Company Overall Sentiment
Aravive Neutral
Trulieve Cannabis Neutral

35.8% of Aravive shares are held by institutional investors. 60.4% of Aravive shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Aravive beats Trulieve Cannabis on 2 of the 3 factors compared between the two stocks.

How does Trulieve Cannabis compare to Atlantic Coastal Acquisition Corp. II?

Trulieve Cannabis (NYSE:TRLV) and Atlantic Coastal Acquisition Corp. II (NASDAQ:ACABW) are both pharmaceutical products companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, earnings, analyst recommendations, institutional ownership, profitability, dividends, risk and media sentiment.

In the previous week, Trulieve Cannabis' average media sentiment score of 0.00 equaled Atlantic Coastal Acquisition Corp. II'saverage media sentiment score.

Company Overall Sentiment
Trulieve Cannabis Neutral
Atlantic Coastal Acquisition Corp. II Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Trulieve Cannabis$1.17B1.38N/AN/AN/A
Atlantic Coastal Acquisition Corp. IIN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Trulieve CannabisN/A N/A N/A
Atlantic Coastal Acquisition Corp. II N/A N/A N/A

Summary

Trulieve Cannabis beats Atlantic Coastal Acquisition Corp. II on 1 of the 1 factors compared between the two stocks.

How does Trulieve Cannabis compare to Biofrontera?

Trulieve Cannabis (NYSE:TRLV) and Biofrontera (NASDAQ:BFRIW) are both pharmaceutical products companies, but which is the better investment? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, risk, valuation, analyst recommendations, dividends, earnings and profitability.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Trulieve Cannabis$1.17B1.38N/AN/AN/A
Biofrontera$43.20MN/AN/AN/AN/A

In the previous week, Biofrontera's average media sentiment score of 1.87 beat Trulieve Cannabis' score of 0.00 indicating that Biofrontera is being referred to more favorably in the news media.

Company Overall Sentiment
Trulieve Cannabis Neutral
Biofrontera Very Positive

Company Net Margins Return on Equity Return on Assets
Trulieve CannabisN/A N/A N/A
Biofrontera N/A N/A N/A

Summary

Trulieve Cannabis and Biofrontera tied by winning 1 of the 2 factors compared between the two stocks.

Get Trulieve Cannabis News Delivered to You Automatically

Sign up to receive the latest news and ratings for TRLV and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TRLV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TRLV vs. The Competition

Export
MetricTrulieve CannabisMedicinal Chemicals IndustryManufacturing SectorNYSE Exchange
Market Cap$1.61B$2.98B$4.28B$23.12B
Dividend YieldN/AN/A10.21%4.06%
P/E RatioN/AN/A22.1831.14
Price / Sales1.380.68210.10108.87
Price / CashN/A0.2741.7124.42
Price / BookN/A748.6923.134.62
Net IncomeN/A-$1.41M$116.61M$1.08B
7 Day PerformanceN/A-26.78%2.07%0.61%
1 Month PerformanceN/A-47.61%0.59%1.94%
1 Year PerformanceN/AN/A14.07%22.49%

Trulieve Cannabis Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TRLV
Trulieve Cannabis
N/A$9.48
+0.9%		N/AN/A$1.61B$1.17BN/A9,000
AIMDW
Ainos
N/A$0.15
-0.4%		N/A+52.0%$0.00$18.11KN/A40
ALVOW
Alvotech
N/A$0.33
-11.2%		N/A-80.6%$0.00$559.42MN/A4
ARAV
Aravive
N/A$0.04
flat		N/AN/A$0.00N/AN/A20
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.00
flat		N/AN/A$0.00N/AN/A15

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NYSE:TRLV) was last updated on 6/17/2026 by MarketBeat.com Staff.
From Our Partners
The 1934 playbook
In 1934, a legal government maneuver transferred billions in wealth overnight. Most Americans never saw it com...
American Alternative | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Is SpaceX really worth 1.78 Trillion?
With SpaceX approaching a near-$2 trillion valuation, most investors are focused on the IPO itself - but analy...
InvestPub | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
The roadshow starts Monday. This stock isn't ready.
The SpaceX roadshow kicks off June 8. Goldman Sachs, the lead underwriter, will present the full S-1 to the wo...
Behind the Markets | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
SpaceX is chump change compared to Elon’s $20T ‘iPhone’
Early Apple investors saw peak gains as high as 7,537% after the iPhone launched. Now, multiple insider source...
StocksToTrade | Sponsoredtc pixel